Future Roadmap

Our long-term development follows a structured plan designed to ensure compliance and sustained growth.

Phase MVP

LIMS MVP development and full CSV documentation (VP, URS, FRS, SDS, IQ/OQ/PQ, RTM).
This phase demonstrates our digital validation capabilities and establishes the foundation for GMP operations.

Phase I: Quality control (QC) pharmaceutical laboratory with proprietary LIMS.

• Phase Ia: Small Molecule QC - Chemistry
• Phase Ib: Small Molecule QC - Microbiology
• Phase Ic: Small Molecule Stability Studies
• Phase Id: Biologics QC - Chemistry
• Phase Ie: Biologics QC - Microbiology
• Phase If: Biologics Stability Studies

Phase II: SaaS Division: TruoX LIMS

• Phase IIa: Sell licenses to non-GxP version of LIMS.
• Phase IIb: Sell licenses to GMP version of LIMS.
• Phase IIc: Sell custom software packages.

Phase III: Contract Manufacturing

• Phase IIIa: Pilot Manufacturing Setup
• Phase IIIb: Small-Batch / Non-Sterile Production
• Phase IIIc: Sterile Manufacturing
• Phase IIId: Quality & Compliance Expansion

Phase IV: Generics Manufacturing

• Phase IVa: Regulatory & Product Selection
• Phase IVb: Formulation & Process Development
• Phase IVc: Scale-Up Manufacturing
• Phase IVd: Market Launch

Phase V: Biomanufacturing

• Phase Va: Infrastructure & Capability Build
• Phase Vb: Biosimilars & Bioprocess Development
• Phase Vc: AI-Driven Design & Automation
• Phase Vd: Regulatory Expansion

Please note that this is only a tentative plan. We are still establishing a timeline so that milestones are realistic.